Luis Malpica Castillo

Luis Malpica Castillo is an Assistant Professor at The University of Texas MD Anderson Cancer Center. His research focuses on lymphoid neoplasia, specifically the epidemiology, clinical features, and outcomes of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma, with a particular emphasis on Latin American populations. He has led international cohort studies published in The Lancet Haematology and Blood Advances, and has investigated cytokine storms in COVID-19, hemophagocytic lymphohistiocytosis, and CAR-T therapy. His recent work includes phase II trials of novel combinations for relapsed CNS lymphomas and advanced-stage follicular lymphoma, alongside translational studies on CD25 expression in ALK+ anaplastic large cell lymphoma.